{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:48:43Z","timestamp":1764784123329,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Flanders Research Foundation"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.coph.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T15:21:28Z","timestamp":1538148088000},"page":"118-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3195-4996","authenticated-orcid":false,"given":"Lucas","family":"Wauters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Vanuytsel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2018.09.005_bib0005","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nrgastro.2009.148","article-title":"Pathophysiology, diagnosis and management of postoperative dumping syndrome","volume":"6","author":"Tack","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2018.09.005_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","article-title":"ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults","volume":"34","author":"Pironi","year":"2015","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2018.09.005_bib0015","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.clnu.2017.06.016","article-title":"Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure","volume":"37","author":"Joly","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2018.09.005_sbref0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.clnu.2017.04.013","article-title":"Clinical classification of adult patients with chronic intestinal failure due to benign disease: an international multicenter cross-sectional survey","volume":"37","author":"Pironi","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2018.09.005_sbref0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/obr.12467","article-title":"Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management","volume":"18","author":"van Beek","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/j.coph.2018.09.005_bib0030","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cgh.2008.11.025","article-title":"Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping","volume":"7","author":"Arts","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2018.09.005_bib0035","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1365-2036.2005.02681.x","article-title":"Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome","volume":"22","author":"Penning","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.005_bib0040","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/j.1365-2036.2006.03124.x","article-title":"Octreotide therapy in dumping syndrome: analysis of long-term results","volume":"24","author":"Didden","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.005_bib0045","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mce.2007.09.006","article-title":"Pasireotide (SOM230): development, mechanism of action and potential applications","volume":"286","author":"Schmid","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.coph.2018.09.005_bib0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/nmo.12333","article-title":"A pilot study of the effects of the somatostatin analog pasireotide in postoperative dumping syndrome","volume":"26","author":"Deloose","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.09.005_sbref0055","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/apt.14664","article-title":"Safety and efficacy of pasireotide in dumping syndrome-results from a phase 2, multicentre study","volume":"47","author":"Tack","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.005_bib0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.regpep.2004.06.018","article-title":"The physiological role of GLP-1 in human: incretin, ileal brake or more?","volume":"128","author":"Schirra","year":"2005","journal-title":"Regul Pept"},{"key":"10.1016\/j.coph.2018.09.005_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/apt.12092","article-title":"Review article: a comparison of glucagon-like peptides 1 and 2","volume":"37","author":"Janssen","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.coph.2018.09.005_bib0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0\u2009mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2018.09.005_bib0075","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ijo.2013.162","article-title":"Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults","volume":"38","author":"van Can","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.coph.2018.09.005_bib0080","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.coph.2018.09.005_bib0085","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s10620-005-3046-2","article-title":"A possible role of GLP-1 in the pathophysiology of early dumping syndrome","volume":"50","author":"Yamamoto","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2018.09.005_bib0090","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00125-016-4179-x","article-title":"Critical role for GLP-1 in symptomatic post-bariatric hypoglycaemia","volume":"60","author":"Craig","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.coph.2018.09.005_bib0095","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1530\/EJE-13-0504","article-title":"GLP1 analogs as treatment of postprandial hypoglycemia following gastric bypass surgery: a potential new indication?","volume":"169","author":"Abrahamsson","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.coph.2018.09.005_bib0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.14309\/crj.2018.1","article-title":"Post-fundoplication dumping syndrome: a frequent \"Rare\" complication","volume":"5","author":"Kataria","year":"2018","journal-title":"ACG Case Rep J"},{"key":"10.1016\/j.coph.2018.09.005_bib0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00464-005-0804-3","article-title":"Gastric emptying of glucose solution and associated plasma concentrations of GLP-1, GIP, and PYY before and after fundoplication","volume":"21","author":"Miholic","year":"2007","journal-title":"Surg Endosc"},{"key":"10.1016\/j.coph.2018.09.005_bib0110","doi-asserted-by":"crossref","first-page":"e6348","DOI":"10.1097\/MD.0000000000006348","article-title":"A case report: liraglutide as a novel treatment option in late dumping syndrome","volume":"96","author":"Chiappetta","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.coph.2018.09.005_bib0115","doi-asserted-by":"crossref","first-page":"S-731","DOI":"10.1016\/S0016-5085(13)62714-6","article-title":"Liraglutide, a long-acting GLP-1 agonist, improves parameters of late dumping syndrome during OGTT in patients without gastrectomy","volume":"144","author":"Vanuytsel","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.09.005_bib0120","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.38.6.859","article-title":"Effect of intestinal resection on human small bowel motility","volume":"38","author":"Schmidt","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.09.005_bib0125","doi-asserted-by":"crossref","first-page":"23S","DOI":"10.1177\/0148607114525210","article-title":"Intestinal adaptation following resection","volume":"38","author":"Tappenden","year":"2014","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2018.09.005_bib0130","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/gut.47.3.370","article-title":"Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon","volume":"47","author":"Jeppesen","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.09.005_bib0135","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/gut.45.4.559","article-title":"Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure","volume":"45","author":"Jeppesen","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.coph.2018.09.005_bib0140","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.clnu.2016.09.002","article-title":"Serum fasting GLP-1 and GLP-2 associate with intestinal adaptation in pediatric onset intestinal failure","volume":"36","author":"Mutanen","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.coph.2018.09.005_bib0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0000000000000120","article-title":"Gut hormones in the treatment of short-bowel syndrome and intestinal failure","volume":"22","author":"Jeppesen","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.coph.2018.09.005_bib0150","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.09.005_sbref0155","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1038\/ctg.2015.69","article-title":"Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"7","author":"Schwartz","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.coph.2018.09.005_bib0160","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ncp.10092","article-title":"Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome-associated intestinal failure: STEPS-3 study","volume":"33","author":"Seidner","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.coph.2018.09.005_bib0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jpen.1011","article-title":"Single-center experience with the use of teduglutide in adult patients with short bowel syndrome","volume":"42","author":"Lam","year":"2018","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2018.09.005_bib0170","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jpen.1149","article-title":"Long-term therapy with teduglutide in parenteral support-dependent patients with short bowel syndrome: a case series","volume":"42","author":"Ukleja","year":"2018","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2018.09.005_bib0175","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MCG.0000000000000604","article-title":"Safety and efficacy of teduglutide (Gattex) in patients with Crohn\u2019s disease and need for parenteral support due to short bowel syndrome-associated intestinal failure","volume":"51","author":"Kochar","year":"2017","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.coph.2018.09.005_sbref0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpeds.2016.10.027","article-title":"Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome","volume":"181","author":"Carter","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.coph.2018.09.005_sbref0185","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1053\/j.gastro.2017.11.023","article-title":"Factors associated with response to teduglutide in patients with short-bowel syndrome and intestinal failure","volume":"154","author":"Jeppesen","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.09.005_bib0190","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0148607116680791","article-title":"Independence from parenteral nutrition and intravenous fluid support during treatment with teduglutide among patients with intestinal failure associated with short bowel syndrome","volume":"41","author":"Iyer","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2018.09.005_bib0195","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1177\/0148607116663481","article-title":"Patients with short bowel on narcotics during 2 randomized trials have abdominal complaints independent of teduglutide","volume":"41","author":"Fujioka","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2018.09.005_bib0200","doi-asserted-by":"crossref","first-page":"G840","DOI":"10.1152\/ajpgi.00505.2011","article-title":"Glucagon-like peptide-2 increases dysplasia in rodent models of colon cancer","volume":"302","author":"Trivedi","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.coph.2018.09.005_bib0205","doi-asserted-by":"crossref","first-page":"S-1359","DOI":"10.1016\/S0016-5085(18)34446-9","article-title":"Glepaglutide, a long-acting glucagon-like peptide-2 analog, improves intestinal absorption of macronutrients, body weight and lean body mass in patients with short bowel syndrome","volume":"154","author":"Hvistendahl","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.09.005_bib0210","doi-asserted-by":"crossref","first-page":"S-160","DOI":"10.1016\/S0016-5085(18)30945-4","article-title":"Effects of short-term treatment with glepaglutide, a long-acting glucagon-like peptide-2 analog, on intestinal morphology and citrulline in patients with short bowel syndrome","volume":"154","author":"Naimi","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.09.005_bib0215","doi-asserted-by":"crossref","first-page":"S-655","DOI":"10.1016\/S0016-5085(18)32328-X","article-title":"Glepaglutide, a glucagon-like peptide-2 analog, ameliorates accelerated gastrointestinal transit time in patients with short bowel syndrome","volume":"154","author":"Hvistendahl","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2018.09.005_bib0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/db15-0893","article-title":"The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial","volume":"65","author":"Thazhath","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.coph.2018.09.005_bib0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.regpep.2013.03.025","article-title":"Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study","volume":"184","author":"Madsen","year":"2013","journal-title":"Regul Pept"},{"key":"10.1016\/j.coph.2018.09.005_bib0230","doi-asserted-by":"crossref","first-page":"739-e328","DOI":"10.1111\/j.1365-2982.2011.01723.x","article-title":"Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome","volume":"23","author":"Kunkel","year":"2011","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2018.09.005_sbref0235","article-title":"Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome: an open-label pilot study","author":"Hvistendahl","year":"2016","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.coph.2018.09.005_bib0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.peptides.2018.06.009","article-title":"Ghrelin stimulates intestinal adaptation following massive small bowel resection in parenterally fed rats","volume":"106","author":"Onishi","year":"2018","journal-title":"Peptides"},{"key":"10.1016\/j.coph.2018.09.005_bib0245","doi-asserted-by":"crossref","first-page":"28345","DOI":"10.1038\/srep28345","article-title":"Enhanced ghrelin levels and hypothalamic orexigenic AgRP and NPY neuropeptide expression in models of jejuno-colonic short bowel syndrome","volume":"6","author":"Gillard","year":"2016","journal-title":"Sci Rep"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218300730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489218300730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:51:03Z","timestamp":1761461463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489218300730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":49,"alternative-id":["S1471489218300730"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2018.09.005","relation":{},"ISSN":["1471-4892"],"issn-type":[{"type":"print","value":"1471-4892"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Applications of peptide hormone ligands for the treatment of dumping and short bowel syndrome","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}